Relapsed/ refractory T-cell malignancies

Clinical trials for Relapsed/ refractory T-cell malignancies explained in plain language.

Never miss a new study

Get alerted when new Relapsed/ refractory T-cell malignancies trials appear

Sign up with your email to follow new studies for Relapsed/ refractory T-cell malignancies, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

New drug cocktail shows promise for Hard-to-Treat blood cancers

Disease control Completed

This early-phase trial tested a combination of four drugs (romidepsin, CC-486, dexamethasone, and lenalidomide) in 26 adults with T-cell cancers that had returned or stopped responding to prior treatments. The main goal was to find a safe dose and check for side effects. While th…

Matched conditions: RELAPSED/ REFRACTORY T-CELL MALIGNANCIES

Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Aug 15, 2026 00:00 UTC

Relapsed/ refractory T-cell malignancies

Get alerted when new Relapsed/ refractory T-cell malignancies trials appear

New drug cocktail shows promise for Hard-to-Treat blood cancers